Efficacy and safety of the novel GlyT1 inhibitor BI 425809 in Alzheimer’s dementia: a randomized controlled trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Efficacy and safety of the novel GlyT1 inhibitor BI 425809 in Alzheimer’s dementia: a randomized controlled trial ; volume:15 ; number:1 ; day:28 ; month:1 ; year:2023 ; pages:1-12 ; date:12.2023
Alzheimer's research & therapy ; 15, Heft 1 (28.1.2023), 1-12, 12.2023
- Urheber
-
Wunderlich, Glen
Blahova, Zuzana
Garcia, Miguel
Jessen, Frank
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-023-01163-3
- URN
-
urn:nbn:de:101:1-2023040421085300878577
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wunderlich, Glen
- Blahova, Zuzana
- Garcia, Miguel
- Jessen, Frank
- SpringerLink (Online service)
Ähnliche Objekte (12)
GlyT1 encephalopathy: characterization of presumably disease causing GlyT1 mutations
Dementia / Alzheimer's Disease
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
Presenilins in Alzheimer’s disease and frontotemporal dementia
Alzheimer’s disease, dementia, and stem cell therapy
Microglial immunophenotype in dementia with Alzheimer’s pathology
Neurovascular dysfunction in vascular dementia, Alzheimer’s and atherosclerosis
Plasma cholesterol in Alzheimer’s disease and frontotemporal dementia
Multimodal deep learning for Alzheimer’s disease dementia assessment
Young-onset Alzheimer’s dementia mimicking progressive myoclonic epilepsy spectrum
Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer’s Dementia
Identification and validation of Alzheimer’s disease-related metabolic brain pattern in biomarker confirmed Alzheimer’s dementia patients
GlyT1 encephalopathy: characterization of presumably disease causing GlyT1 mutations
Dementia / Alzheimer's Disease
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
Presenilins in Alzheimer’s disease and frontotemporal dementia
Alzheimer’s disease, dementia, and stem cell therapy
Microglial immunophenotype in dementia with Alzheimer’s pathology
Neurovascular dysfunction in vascular dementia, Alzheimer’s and atherosclerosis
Plasma cholesterol in Alzheimer’s disease and frontotemporal dementia
Multimodal deep learning for Alzheimer’s disease dementia assessment
Young-onset Alzheimer’s dementia mimicking progressive myoclonic epilepsy spectrum
Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer’s Dementia
Identification and validation of Alzheimer’s disease-related metabolic brain pattern in biomarker confirmed Alzheimer’s dementia patients
GlyT1 encephalopathy: characterization of presumably disease causing GlyT1 mutations
Dementia / Alzheimer's Disease
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
Presenilins in Alzheimer’s disease and frontotemporal dementia
Alzheimer’s disease, dementia, and stem cell therapy
Microglial immunophenotype in dementia with Alzheimer’s pathology
Neurovascular dysfunction in vascular dementia, Alzheimer’s and atherosclerosis
Plasma cholesterol in Alzheimer’s disease and frontotemporal dementia
Multimodal deep learning for Alzheimer’s disease dementia assessment
Young-onset Alzheimer’s dementia mimicking progressive myoclonic epilepsy spectrum
Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer’s Dementia